An oral targeted therapy approved for pancreatic cancer showed antitumor activity in previously treated lung cancer, according to early-phase data published Sept. 2 in The New England Journal of Medicine. The drug, Rasonque (daraxonrasib), is an oral RAS inhibitor from…
Pharmacy
The FDA has announced a request for information to gather public input on ways to advance the development of botanical drug products, according to a Sept. 3 agency news release. Botanical drug products are derived from plant materials, algae or…
On Aug. 26, the FDA approved daraxonrasib, brand name Rasonque, for adults with advanced pancreatic cancer that has stopped responding to chemotherapy. The approval came three months after a landmark study found the drug extended progression-free survival by a median…
The 5th U.S. Circuit Court of Appeals affirmed Aug. 27 that the FDA acted lawfully when it declared Eli Lilly’s tirzepatide shortage resolved, according to court documents reviewed by Becker’s The ruling delivers a defeat to compounding pharmacies that had…
Hartford, Conn.-based Saint Francis Hospital has launched a program offering free prescription medications to uninsured, low-income patients with chronic illnesses. The program, launched through a partnership with Dispensary of Hope, provides medications through the Saint Francis Rx Pharmacy, according to…
Despite still being viewed by many as laggard when it comes to technology adoption, the healthcare industry has made some progress in this area over the past decade. The electronic health record (EHR) is a case in point. Most health…
Active U.S. drug shortages increased to 227 in the second quarter of 2026, marking the third consecutive quarterly increase, according to the American Society of Health-System Pharmacists. Nearly half of all new shortages this year involve medications made by a…
Baxter International has recalled one lot each of 70% Dextrose Injection and Anticoagulant Sodium Citrate Solution due to the potential presence of particulate matter. The 70% Dextrose Injection may contain stainless steel particles, according to an Aug. 25 FDA alert.…
Novartis temporarily paused eight clinical trials of its experimental CAR-T therapy in late August after three patients died from a severe immune response, The Wall Street Journal reported Sept. 1. The Switzerland-based drugmaker was testing the treatment — called rap-cel…
Louisiana Attorney General Liz Murrill has filed a lawsuit against Express Scripts and its affiliate Ascent Health Services, alleging the companies manipulated Louisiana’s prescription drug market. The state alleges Express Scripts and its partners restricted competition, manipulated pharmacy reimbursement rates,…